ARTICLE | Clinical News
Reolysin: Additional Phase II data
April 20, 2015 7:00 AM UTC
Additional data from the open-label, U.S. Phase II REO 017 trial in 33 chemotherapy-naive patients with advanced or metastatic pancreatic cancer showed that first-line treatment with IV Reolysin plus ...